commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Our proprietary RxSight LighAdjustable Lens system (“RxSight system”), comprised of our RxSight LightA Adjustable Lens (“LAL”), RxSight Light Delivery Device (“LDD”) and accessories, t is the first and only commercially available intraocular lens (“IOL”) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
Lead Underwriter
BofA Securities, Inc, J.P. Morgan Securities LLC, SVB Leerink LLC
